Niagen Bioscience (NAGE) Competitors $10.10 +0.37 (+3.80%) As of 05/14/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock NAGE vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CALAShould you be buying Niagen Bioscience stock or one of its competitors? The main competitors of Niagen Bioscience include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry. Niagen Bioscience vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Calithera Biosciences 180 Life Sciences (NASDAQ:ATNFW) and Niagen Bioscience (NASDAQ:NAGE) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, community ranking, media sentiment, valuation and risk. Which has better earnings and valuation, ATNFW or NAGE? Niagen Bioscience has higher revenue and earnings than 180 Life Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ANiagen Bioscience$99.60M7.98$13.38M$0.1759.41 Do insiders and institutionals have more ownership in ATNFW or NAGE? 15.4% of Niagen Bioscience shares are owned by institutional investors. 9.6% of Niagen Bioscience shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is ATNFW or NAGE more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Niagen Bioscience N/A N/A N/A Does the media refer more to ATNFW or NAGE? In the previous week, Niagen Bioscience had 2 more articles in the media than 180 Life Sciences. MarketBeat recorded 3 mentions for Niagen Bioscience and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.89 beat Niagen Bioscience's score of 0.58 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Very Positive Niagen Bioscience Positive Does the MarketBeat Community prefer ATNFW or NAGE? 180 Life Sciences and Niagen Bioscience both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ANiagen BioscienceN/AN/A SummaryNiagen Bioscience beats 180 Life Sciences on 4 of the 5 factors compared between the two stocks. Get Niagen Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for NAGE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAGE vs. The Competition Export to ExcelMetricNiagen BioscienceMedicinal Chemicals IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$794.71M$794.71M$2.09B$8.47BDividend YieldN/AN/A2.65%4.19%P/E Ratio59.4129.7122.7619.71Price / Sales7.987.9864.51120.61Price / CashN/AN/A51.7234.62Price / BookN/AN/A2.024.51Net Income$13.38MN/A-$333.48M$247.94M7 Day Performance19.53%19.53%6.20%5.23%1 Month Performance64.50%64.50%10.13%11.44%1 Year PerformanceN/AN/A9.88%6.23% Niagen Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAGENiagen BioscienceN/A$10.10+3.8%N/AN/A$794.71M$99.60M59.41120News CoverageATNFW180 Life SciencesN/A$0.01-15.5%N/A-1.1%$0.00N/A0.007Gap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01flatN/A-78.3%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.13-14.6%N/A+146.8%$0.00$20,729.000.0040ALVOWAlvotechN/A$1.79+23.4%N/A-38.8%$0.00$489.68M0.004ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02flatN/A-79.5%$0.00N/A0.0015BFRIWBiofronteraN/A$0.03-38.0%N/A+60.5%$0.00$37.32M0.0070Gap UpBTMDWbioteN/A$0.01-15.7%N/A-94.3%$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.06-10.0%N/A-94.5%$0.00N/A0.008Gap DownCALACalithera BiosciencesN/AN/AN/A-97.0%$0.00N/A0.0060Analyst ForecastGap Down Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ACABW Competitors BFRIW Competitors BTMDW Competitors BCTXW Competitors CALA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAGE) was last updated on 5/15/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Niagen Bioscience Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Niagen Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NAGE Stock Free NAGE Stock Alerts